Le Lézard
Classified in: Health
Subjects: AWD, TDS, TRI

Top scientists at Swiss conference reported promising leads on microbial triggers of Alzheimer's, says Dr. Leslie Norins, CEO of Alzheimer's Germ Quest


NAPLES, Fla., Nov. 12, 2018 /PRNewswire/ -- Leading researchers from the U.S., U.K., and Europe at a Swiss conference last month reported progress on incriminating several infectious agents as possible triggers of Alzheimer's disease, says Leslie Norins, MD, PhD, a speaker and CEO of Alzheimer's Germ Quest, Inc. The independent advocacy group sponsors the $1 million challenge award for the scientist who proves a "germ" of some sort causes Alzheimer's.

Dr. Norins says this breadth of serious evidence from credentialed investigators in several countries confirms his group's decision to offer the $1 million challenge award as a help to continuing momentum for examining microbes.

He says several participants informally told him their proposals to pinpoint the role of the bacterial and viral suspects were stalled because the major grant agencies seem prejudiced against funding investigations of any microbe as the root cause of Alzheimer's. Instead, they are allocating most of the billions of Alzheimer's research dollars available worldwide this year to additional studies of the same two brain proteins favored for two decades, amyloid plaques and tau tangles.

The principal categories of infectious agents discussed were herpes viruses, spirochetes, and chlamydia. An unusual bacterium, Bartonella, was also flagged. The new view of brain amyloid as an innate immune defense, rather than "trash", was also presented.

Gingivitis (infected gums) received attention from three speakers, because the oral spirochetes which multiply in the inflamed tissue around the teeth can access the brain. Even ordinary tooth brushing can send showers of these supposedly harmless germs into the bloodstream. Dr. Judith Miklossy, conference chair, reported spirochetes, found in the brains of Alzheimer's patients, could manufacture the amyloid seen, but other attendees believed it was produced by brain cells and not microbes.

The event, held in Crans-Montana, was organized by the Prevention Alzheimer International Foundation, Switzerland.

Alzheimer's Germ Quest, Inc. is a public benefit corporation headquartered in Naples, Florida. Its mission is to accelerate and deepen the search for an infectious organism possibly causing Alzheimer's disease. It neither solicits nor accepts outside donations.

 

SOURCE Alzheimer's Germ Quest, LLC


These press releases may also interest you

at 19:30
Astellas Pharma Inc....

at 19:15
Denver nonprofit Justice Necessary unveils data from its latest study on teen period poverty in Colorado, shedding light on a deeply concerning issue. The findings of this study underscore the urgent need for action to address the need for teens to...

at 19:05
Xaira Therapeutics launched today on a mission to help re-engineer the way we discover and develop medicines through the end-to-end application of emerging AI technologies. A joint incubation by ARCH Venture Partners and Foresite Labs, Xaira launched...

at 18:00
Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM. MamaLift Plus is the first prescription digital therapeutic for the treatment of postpartum depression (PPD), a...

at 17:45
BioSyent Inc. ("BioSyent", TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th ? May 2nd at the Paris Hotel & Casino. Mr. René Goehrum, President and CEO of BioSyent,...

at 17:44
United Breast Cancer Foundation (UBCF) is proud to host a heartfelt event dedicated to honor the memory of Audrey Beverly Christy Mastroianni, a remarkable Rhode Island woman who bravely battled breast cancer. The "Gifts of Comfort and Hope" Mattress...



News published on and distributed by: